Phio Pharmaceuticals Corp.

Industry

  • Biotechnology
    • Antisense, Oligonucleotides
    • Drug Discovery Technologies
      • Genomics-Proteomics
      • Molecular Diversity
      • ADMET
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery

Other Names/Subsidiaries

  • Apthera, Inc.
  • MirImmune, Inc.
  • RXi Pharmaceuticals Corp.
See more in Biomedtracker

Latest on Phio Pharmaceuticals Corp.

Scrip

Deal Watch: AI Specialist Biolojic Inks Diabetes Pact With Lilly, Autoimmune Tie-Up With Nektar

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biolojic To Use Computational Platform

Scrip

Tech Transfer Roundup: Tonix Obtains Triple-Reuptake Inhibitor For PTSD From Wayne State

 
• By Joseph Haas

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Tonix Li

Scrip

Phio Pharma Takes RXi’s Self-Delivering RNAi Technology, Refocuses On Immuno-Oncology

 
• By Joseph Haas

RXi Pharmaceuticals Corp.was humming along in early 2017, developing clinical candidates for dermatology and ophthalmology with its self-delivering RNA-interference (sd-rxRNA) technology, when Gerrit

Scrip

Tech Transfer Roundup: Mustang Licenses St. Jude’s Gene Therapy For Bubble Boy Disease

 
• By Joseph Haas

Below is Scrip’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Mustang